Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Commenced operations in flood-affected Himachal Pradesh
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Lupin has been exclusively marketing these brands in the Indian market since July 2021
The companies will work with investigators to share the results with the scientific community
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
Subscribe To Our Newsletter & Stay Updated
